glp-1 brain inflammation Beyond diabetes and obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation - Spezani - 2026 - Diabetes, Obesity and Metabolism GLP-1 drugs tied to lower

Fassina P, Scherer Adami F, Terezinha Zani V, Kasper Machado IC, Garavaglia J, Quevedo Grave MT, Ramos R, Morelo Dal Bosco S

Risk-Benefit Assessment : The potential benefits must be carefully weighed against known and unknown risks, particularly given the limited long-term safety data in adolescents

Article R, Shah MS, Madhuri T, Monika W (2020) Herbal supplements used in schizophrenia 9:842857

Whether these receptors (GCGR, GIPR, GLP-1R) are expressed as proteins in the mouse atrium is currently not clear because the specificity of commercial antibodies against these three receptors is doubtful and controversial (Neumann et al